Galen Perry
602.343.8423
gperry@tgen.org
Steve Yozwiak
602.343.8704
syozwiak@tgen.org
|
|
Media Releases
Translational Genomics Research Institute (TGen) finalizes alliance with Van Andel Research Institute (VARI)
February 5 2010
TGen today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute...
TGen and Geisinger Health System Announce Strategic Partnership to Shape Future of Personalized Medicine
Obesity and diabetes focus of first study
February 3 2010
TGen and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine...
The Translational Genomics Research Institute (TGen) becomes center of excellence for Horizon Discovery’s GENESIS and X-MAN technology
February 2 2010
The Translational Genomics Research Institute (TGen) becomes center of excellence for Horizon Discovery’s GENESIS and X-MAN technology...
Modern physician training fueled by $300,000 grant to TGen
Life Technologies Foundation speeds knowledge of molecular medicine
February 1 2010
The philanthropic arm of Life Technologies has announced $5 million in doctor-training grants, including $300,000 for TGen...
New study shows TGen spin-off boosts Scottsdale economy
TGen Drug Development (TD2) creates jobs, revenues, related businesses; Total economic impact on the city in 2015 is projected to top $239 million
January 21 2010
TGen Drug Development (TD2) creates jobs, revenues, related businesses; Total economic impact on the city in 2015 is projected to top $239 million...
Researchers identify proteins that might contribute to memory loss and Alzheimer’s disease
TGen-led team finds 3 proteins that dismantle ‘bridges’ within brain cells
January 15 2010
A scientific group led by TGen have identified three kinases, or proteins, that dismantle connections within brain cells...
TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
MicroRNAs are key to identifying patients resistant to ‘first-line’ chemotherapy
January 13 2010
Researchers for TGen Clinical Research Services at Scottsdale Healthcare (TCRS) have identified a way to predict which patients with small-cell lung cancer may be resistant...
TD2 and Critical Outcome Technologies Inc. develop novel anti-cancer drug
World renowned clinical oncologist and TGen Drug Development chosen to lead drug development program for COTI-2
January 12 2010
TD2 and COTI announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug...
Circumcision associated with significant changes in bacteria
Changes in bacteria within the penis microbiome documented for the first time
January 5 2010
Circumcision, which substantially lowers HIV risk in men, also dramatically changes the bacterial communities of the penis, according to a study led by scientists at TGen...
TGen analysis identifies biomarkers for diabetic kidney failure
Pooled DNA technique identifies variances that could indicate susceptibility to end-stage renal disease
December 16 2009
Researchers using a DNA analysis tool developed by TGen and UCLA have identified genetic markers that could help treat chronic kidney disease...
[more] 11 of 205 >>
|
|
|
|
|
|